Johnson & Johnson Future Growth
Future criteria checks 2/6
Johnson & Johnson is forecast to grow earnings and revenue by 9.4% and 0.9% per annum respectively. EPS is expected to grow by 12.3% per annum. Return on equity is forecast to be 32.3% in 3 years.
Key information
9.4%
Earnings growth rate
12.3%
EPS growth rate
Pharmaceuticals earnings growth | 19.9% |
Revenue growth rate | 0.9% |
Future return on equity | 32.3% |
Analyst coverage | Good |
Last updated | 22 Jan 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 92,552 | 23,440 | 23,791 | 28,175 | 10 |
12/31/2025 | 90,441 | 22,415 | 23,616 | 27,536 | 18 |
12/31/2024 | 87,949 | 20,820 | 23,016 | 26,483 | 20 |
12/31/2023 | 84,764 | 17,242 | 19,922 | 22,297 | 20 |
10/1/2023 | 98,656 | 13,992 | 15,737 | 20,278 | N/A |
7/2/2023 | 97,301 | 13,993 | 14,547 | 19,073 | N/A |
4/2/2023 | 96,263 | 12,724 | 16,207 | 20,472 | N/A |
1/1/2023 | 94,943 | 17,941 | 17,185 | 21,194 | N/A |
10/2/2022 | 84,855 | 17,879 | 17,739 | 21,576 | N/A |
7/3/2022 | 88,197 | 17,236 | 19,950 | 23,582 | N/A |
4/3/2022 | 94,880 | 19,830 | 19,733 | 23,315 | N/A |
1/2/2022 | 93,775 | 20,878 | 19,758 | 23,410 | N/A |
10/3/2021 | 91,446 | 17,880 | 22,461 | 26,021 | N/A |
7/4/2021 | 89,190 | 17,767 | 22,564 | 26,114 | N/A |
4/4/2021 | 84,214 | 15,115 | 20,853 | 24,252 | N/A |
1/3/2021 | 82,584 | 14,714 | 20,189 | 23,536 | N/A |
9/27/2020 | 80,856 | 16,986 | 18,307 | 21,591 | N/A |
6/28/2020 | 80,503 | 15,185 | 17,443 | 20,735 | N/A |
3/29/2020 | 82,729 | 17,166 | 19,764 | 23,231 | N/A |
12/29/2019 | 82,059 | 15,119 | 19,918 | 23,416 | N/A |
9/29/2019 | 81,706 | 14,151 | 19,706 | 23,262 | N/A |
6/30/2019 | 81,325 | 16,332 | 18,377 | 22,007 | N/A |
3/31/2019 | 81,593 | 14,679 | 18,470 | 22,138 | N/A |
12/30/2018 | 81,581 | 15,297 | 18,531 | 22,201 | N/A |
9/30/2018 | 81,382 | 1,542 | 18,470 | 22,062 | N/A |
7/1/2018 | 80,684 | 1,372 | 18,493 | 22,056 | N/A |
4/1/2018 | 78,693 | 1,245 | 18,372 | 21,749 | N/A |
12/31/2017 | 76,450 | 1,300 | 17,777 | 21,056 | N/A |
10/1/2017 | 74,361 | 15,827 | 18,472 | 21,604 | N/A |
7/2/2017 | 72,531 | 16,335 | N/A | 20,699 | N/A |
4/2/2017 | 72,174 | 16,505 | N/A | 19,491 | N/A |
1/1/2017 | 71,890 | 16,540 | N/A | 18,767 | N/A |
10/2/2016 | 71,595 | 15,941 | N/A | 17,199 | N/A |
7/3/2016 | 70,877 | 15,027 | N/A | 17,978 | N/A |
4/3/2016 | 70,182 | 15,546 | N/A | 18,886 | N/A |
1/3/2016 | 70,074 | 15,409 | N/A | 19,569 | N/A |
9/27/2015 | 70,517 | 14,715 | N/A | 18,849 | N/A |
6/28/2015 | 71,882 | 16,106 | N/A | 17,363 | N/A |
3/29/2015 | 73,590 | 15,916 | N/A | 17,420 | N/A |
12/28/2014 | 74,331 | 16,323 | N/A | 18,710 | N/A |
9/28/2014 | 74,232 | 17,321 | N/A | 18,245 | N/A |
6/29/2014 | 73,340 | 15,554 | N/A | 19,538 | N/A |
3/30/2014 | 71,722 | 15,061 | N/A | 19,060 | N/A |
12/29/2013 | 71,312 | 13,831 | N/A | 17,414 | N/A |
9/29/2013 | 70,515 | 12,879 | N/A | 16,651 | N/A |
6/30/2013 | 69,992 | 12,865 | N/A | 15,684 | N/A |
3/31/2013 | 68,590 | 10,440 | N/A | 14,878 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DJNJ2's forecast earnings growth (9.4% per year) is above the savings rate (8.1%).
Earnings vs Market: DJNJ2's earnings (9.4% per year) are forecast to grow slower than the AR market (42.1% per year).
High Growth Earnings: DJNJ2's earnings are forecast to grow, but not significantly.
Revenue vs Market: DJNJ2's revenue (0.9% per year) is forecast to grow slower than the AR market (32.3% per year).
High Growth Revenue: DJNJ2's revenue (0.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: DJNJ2's Return on Equity is forecast to be high in 3 years time (32.3%)